Anandamide-derived prostamide F2α negatively regulates adipogenesis

49Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Background: Adipogenesis is the process by which adipocytes are formed to maintain or expand fat depots. Results: Prostaglandin F2α ethanolamide (PGF2αEA) is produced from anandamide in preadipocytes and inhibits adipogenesis. Conclusion: Conversion of proadipogenic anandamide to antiadipogenic PGF2αEA is a novel mechanism for the regulation of adipogenesis. Significance: Discovering a PGF 2αEA-mediated negative regulatory mechanism over adipogenesis may lead to the development of antiobesity therapies. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Silvestri, C., Martella, A., Poloso, N. J., Piscitelli, F., Capasso, R., Izzo, A., … Di Marzo, V. (2013). Anandamide-derived prostamide F2α negatively regulates adipogenesis. Journal of Biological Chemistry, 288(32), 23307–23321. https://doi.org/10.1074/jbc.M113.489906

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free